Odyssey Healthcare Inc

Odyssey Healthcare — Investor Presentation (March 2007)

35 slides from Odyssey Healthcare's investor presentation, Mar 13, 2007

  1. Slide 1: To Serve All People During the End of Life's Journey

    Slide 1: To Serve All People During the End of Life's Journey

    “To Serve All People During the End of Life’s Journey”

  2. Slide 2: Forward-Looking Statements

    Slide 2: Forward-Looking Statements

    Forward-Looking Statements Forward-Looking Statements Certain statements contained in this presentation are forward-looking statements within the meaning of the federal securities laws. Such forward-looking statements are based on management’s current expectations and are subject to known and unknow

  3. Slide 3: Odyssey… A Leader in Hospice Care

    Slide 3: Odyssey… A Leader in Hospice Care

    Odyssey… A Leader in Hospice Care 80 Medicare Certified Programs in 30 states 34,065 admissions in 2006 CAGR revenue = 25.8% 80 Medicare Certified

  4. Slide 4: Investment Highlights

    Slide 4: Investment Highlights

    Investment Highlights ⑀⍵ Favorable growth demographics ⑀⍵ CMS acknowledges value of industry ⑀⍵ Experienced management team ⑀⍵ New growth strategies ⑀⍵ Strong balance sheet and cash flow

  5. Slide 5: Odyssey Locations

    Slide 5: Odyssey Locations

    Odyssey Locations Odyssey Locations Hospice Office Inpatient Facility Corporate Office - Dallas

  6. Slide 6: What is Hospice?

    Slide 6: What is Hospice?

    What is Hospice? What is Hospice? Provides quality of life for terminal patients and families Provides quality of life for terminal patients and families Focus on physical, emotional and spiritual Focus on physical, emotional and spiritual More cost effective More cost effective Services provided pr

  7. Slide 7: Four Levels of Care

    Slide 7: Four Levels of Care

    Four Levels of Care Four Levels of Care *Per diem rates vary by geographic location Routine Routine ⑀⍵ $129 per diem* ⑀⍵ At patient’s residence, including nursing home ⑀⍵ Approximately 90% of the market ⑀⍵ $129 per diem* ⑀⍵ At patient’s residence, including nursing home ⑀⍵ Approximately 90% of the m

  8. Slide 8: Covered by Medicare

    Slide 8: Covered by Medicare

    Covered by Medicare Covered by Medicare Benefit enacted in 1983 Benefit enacted in 1983 Aggregate per beneficiary cap of $20,585 Aggregate per beneficiary cap of $20,585 Six months life expectancy Six months life expectancy Largest payer at > 90% is Medicare Largest payer at > 90% is Medicare Servic

  9. Slide 9: Market Opportunity

    Slide 9: Market Opportunity

    Market Opportunity Sudden Death/Other Hospice Patients Served 41% 2.5 million deaths annually in U.S. 42% Under-Served Market 17%

  10. Slide 10: Patients by Diagnosis in the Industry

    Slide 10: Patients by Diagnosis in the Industry

    Patients by Diagnosis in the Industry Patients by Diagnosis in the Industry Heart Disease 12.2% 12.2% 20% 20% 8.9% 8.9% 46% 46% 8.2% 8.2% 3.1% 3.1% Other Dementia Cancer Lung Disease Kidney Disease Liver Disease 1.6%

  11. Slide 11: Rapidly Growing Market

    Slide 11: Rapidly Growing Market

    Rapidly Growing Market Hospice Medicare Expenditures ($ in billions) $2.9 $3.6 $4.5 $5.7 $8.2 FY 2000 FY 2001 FY 2002 FY 2003 FY 2005 $6.9 FY 2004

  12. Slide 12: Hospice Market - Growth Factors

    Slide 12: Hospice Market - Growth Factors

    Hospice Market - Growth Factors Hospice Market - Growth Factors Increased length of stay Increased penetration - greater understanding and acceptance Additional diagnosis utilizing hospice Aging population

  13. Slide 13: Hospice Market

    Slide 13: Hospice Market

    Hospice Market Hospice Market Non-profit & Government 54% 54% Approximately 2,850 hospice programs in 2005 46% 46% For profit

  14. Slide 14: Hospice Types

    Slide 14: Hospice Types

    Hospice Types Hospice Types SNF-based 1% Home Health-based 23% 23% 19% 19% 57% 57% Hospital-based Free Standing

  15. Slide 15: Strategic Focus

    Slide 15: Strategic Focus

    Strategic Focus Strategic Focus ⑀⍵ Service excellence ⑀⍵ Refine growth strategies ⑀⍵ Continue development of new inpatient units ⑀⍵ Balance top line growth with a more disciplined approach to infrastructure and costs

  16. Slide 16: Growth Strategy

    Slide 16: Growth Strategy

    Growth Strategy Growth Growth Same store growth Same store growth De Novos De Novos Acquisitions Acquisitions

  17. Slide 17: Same Store Growth

    Slide 17: Same Store Growth

    Same Store Growth Same Store Growth Expanding continuum of care to increase market share Expanding continuum of care to increase market share Leverage footprint by opening alternate delivery sites Leverage footprint by opening alternate delivery sites Continue to refine basic sales strategy Continue

  18. Slide 18: Distribution by Program Size

    Slide 18: Distribution by Program Size

    Distribution by Program Size Distribution by Program Size Q4 2006 0 - 50 51 - 100 101 - 200 201+ Patients Patients Patients Patients # of Programs 20 24 31 6 Avg. Size 32 ADC 77 ADC 144 ADC 243 ADC Avg. Revenue $404,557 $909,230 $1,808,084 $3,019,820 Avg. Net Margin (1.9)% 12.6% 20.6% 27.8%

  19. Slide 19: Criteria for De Novos

    Slide 19: Criteria for De Novos

    Criteria for De Novos ⑀⍵Growing markets ⑀⍵Broad base of referral sources ⑀⍵Competitive advantage ⑀⍵Regulatory environment

  20. Slide 20: Acquisitions

    Slide 20: Acquisitions

    Acquisitions Acquisitions Strategic acquisitions ⑀⍽ Cap management ⑀⍽ Market entry ⑀⍽ Market consolidation Strong cash position and balance sheet Disciplined pricing strategy

  21. Slide 21: Medicare "Cap"

    Slide 21: Medicare "Cap"

    Medicare “Cap” Medicare “Cap” ⑀⍵Sets a limit on reimbursement per provider number ⑀⍵Determined on an annual basis at program level ⑀⍵$20,585 x number of adjusted admissions = limit

  22. Slide 22: Medicare Cap Management

    Slide 22: Medicare Cap Management

    Medicare Cap Management Medicare Cap Management ⑀⍵ Increase short-term admissions ⑀⍵ Balance mix of patients ⑀⍵ Manage length of stay ⑀⍵ Open inpatient units

  23. Slide 23: Medicare Cap Performance

    Slide 23: Medicare Cap Performance

    Medicare Cap Medicare Cap Performance Level - % of Peak 80 - 100% 50 - 80 % < 50 % % of Cap Limit 80 - 105% 50 - 80% 105 - 115% < 50% > 115% Percentage of Programs 9.9% 46.9% 7.4% 33.3% 2.5%

  24. Slide 24: Inpatient Unit Development

    Slide 24: Inpatient Unit Development

    Inpatient Unit Development Inpatient Unit Development ⑀⍵ Two strategies ⑀⍽ Medicare cap - acute, short stay patients ⑀⍽ Grow market share - create differentiation ⑀⍵ Five to six new projects during 2007 ⑀⍵ Opening losses ⑀⍽ Pre-opening loss - $400,000 ⑀⍽ Additional loss before breakeven - $300,000 ⑀

  25. Slide 25: Odyssey HealthCare Financial Summary

    Slide 25: Odyssey HealthCare Financial Summary

    Odyssey HealthCare Financial Summary

  26. Slide 26: Net Revenue Growth

    Slide 26: Net Revenue Growth

    Net Revenue Growth Net Revenue Growth CAGR = 25.8% CAGR = 25.8% 2001 $130.2 2002 $194.5 2003 $270.2 2004 $340.2 $409.8 2006 2005 $378.1

  27. Slide 27: Admissions

    Slide 27: Admissions

    Admissions Admissions 15,969 22,062 26,602 30,614 34,056 33,024 2001 2002 2003 2004 2006 2005

  28. Slide 28: Average Length of Stay

    Slide 28: Average Length of Stay

    Average Length of Stay Average Length of Stay (Days) 2003 74 2004 79 2005 82 2006 86

  29. Slide 29: Average Daily Census

    Slide 29: Average Daily Census

    Average Daily Census Average Daily Census 3,044 4,407 5,936 7,383 7,907 8,350 2001 2002 2003 2004 2006 2005

  30. Slide 30: Income from Continuing Operations

    Slide 30: Income from Continuing Operations

    Income from Continuing Operations Income from Continuing Operations * Excluding charge for settlement with Department of Justice of $9.6 million, net of tax ** Income from continuing operations excluding stock compensation expenses of $3.0 million, Medicare cap adjustments related to prior periods o

  31. Slide 31: Reconciliation of Non-GAAP Financial Measures

    Slide 31: Reconciliation of Non-GAAP Financial Measures

    Reconciliation of Non-GAAP Financial Measures ($ in millions) Reconciliation of Non-GAAP Financial Measures ($ in millions) Income from continuing operations Add: Government settlement Less: Provision for income taxes Adjusted income from continuing operations Income from continuing operations Add:

  32. Slide 32: Net Cash from Continuing Operations

    Slide 32: Net Cash from Continuing Operations

    Net Cash from Continuing Operations Net Cash from Continuing Operations ($ in millions) * Exclusive of $13 million for Department of Justice payment $27.6 2003 $47.1 2004 $58.6 2005 $47.9* 2006

  33. Slide 33: 2007 Guidance

    Slide 33: 2007 Guidance

    2007 Guidance 2007 Guidance Net patient revenues $433 - $443 million EPS continuing ops $0.68 - $0.73 Average daily census 8,400 - 8,700 Medicare cap allowance as % of gross revenues 2.8% - 3.0% De novo units 3 - 4 IPUs 5 - 6; loss of $3.6 million Bad debt expense 1 - 1.2% Cap Ex approximately 6.6 m

  34. Slide 34: Investment Highlights

    Slide 34: Investment Highlights

    Investment Highlights Investment Highlights ⑀⍵ Favorable growth demographics ⑀⍵ CMS acknowledges value of industry ⑀⍵ Experienced management team ⑀⍵ New growth strategies ⑀⍵ Strong balance sheet and cash flow

  35. Slide 35: Odyssey HealthCare: To Serve All People During the End of Life's Journey

    Slide 35: Odyssey HealthCare: To Serve All People During the End of Life's Journey

    Odyssey HealthCare “To Serve All People During the End of Life’s Journey”

Source: SEC EDGAR · 8-K filed Mar 13, 2007

More decks from Odyssey Healthcare Inc